Half of patients with Parkinson’s disease (PD) and psychosis receive prescriptions for anti-psychotic (AP) agents, including drugs that have the potential to worsen Parkinson symptoms, and the frequency of use of these agents has not changed since a warning about using these drugs in patients with dementia and PD was issued, according to a new study.